Guangdong Hongshi Laser Technology Co., Ltd. (HSG Laser) has failed to complete its initial public offering (IPO), marking a ...

The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.

This is ESR’s first REIT in China, and comprises three stabilised logistics facilities that have an average occupancy of 90%.

A global biopharma with a U.S. headquarters in Montgomery County is gearing up to go public on a U.S. exchange.

Chinese self-driving truck developer Inceptio is exploring the possibility of a US intial public offering to raise between ...

Ascentage Pharma said on Tuesday it was targeting a valuation of $1.75 billion in its initial public offering, becoming the ...

Within days of its $4.4 billion IPO on the New York Stock Exchange last June, the Chinese ride-hailing giant Didi Global got ...

With nine IPO exits achieved in the first three quarters of 2024, CICC Capital – the PE investment arm of state-owned investment bank China International Capital Corp – was the best-performing ...

Today’s episode discusses the recovery of global tourism, Hopper’s possible IPO, and the impact of Trump’s orders on tourism.

Ascentage Pharma said on Thursday it aims to raise $126.4 million in an initial public offering in the United States, becoming the first sizeable Chinese firm to seek a listing in the U.S. this year.

The country’s top pork processor reveals the size and price range of its long-rumored separation from China’s WH Group, but a ...

Phoenix Asia Holdings faces significant risks, including regulatory risks, customer concentration and uncertainties in the ...